Identification of Targetable HER2 Aberrations in Head and Neck Squamous Cell Carcinoma

IMPORTANCE: HER2 is an important drug target in breast cancer, where anti-HER2 therapy has been shown to lead to improvements in disease recurrence and overall survival. HER2 status in head and neck squamous cell carcinoma (HNSCC) has not been well studied. Identification of HER2 positive tumors and...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:JAMA Otolaryngol Head Neck Surg
Main Authors: Birkeland, Andrew C., Yanik, Megan, Tillman, Brittny N., Scott, Megan V., Foltin, Susan K., Mann, Jacqueline E., Michmerhuizen, Nicole L., Ludwig, Megan L., Sandelski, Morgan M., Komarck, Christine M., Carey, Thomas E., Prince, Mark E.P., Bradford, Carol R., McHugh, Jonathan B., Spector, Matthew E., Brenner, J. Chad
Formato: Artigo
Idioma:Inglês
Publicado em: 2016
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4911238/
https://ncbi.nlm.nih.gov/pubmed/27077364
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaoto.2016.0335
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados